PATENT CLAIM ANALYSIS

Application Number: 15941644
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "408000"]

Abstract:
Disclosed herein are sustained release Liothyronine oral capsule formulations, methods of making the formulations and use to treat hypothyroidism, a thyroid deficient disease state, or thyroid dysfunction.

Claim (Index 10):
The capsule formulation of  claim 1 , wherein the capsule formulation exhibits an in vitro dissolution profile that is substantially a zero order or Higuchi release kinetic pattern when tested using a USP paddle (Type II) apparatus at a temperature of 37\u00b0 C.\u00b10.2\u00b0 C. and RPM of 50\u00b10.1 per minute using 1000 mL phosphate buffered saline (pH=7.3\u00b10.1) as the dissolution medium.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.14815
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15912438', '13498751', '12097163', '14776386', '14062759']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7399970527617352
- 35 USC 102 Novelty (BERT): 0.5068150273690425
- Combined Prediction Score: 0.7166788502224659
- Mean Citation Score: 224.737068
- Max Citation Score: 237.49814
- Similarity Product: 151.25911313850284

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test